Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
GTT Communications, Inc. stock logo
GTT
GTT Communications
$2.08
$1.37
$8.38
$138.81M1.445.28 million shs106,327 shs
KDI
Kennady Diamonds
C$2.95
-1.7%
C$2.95
C$2.45
C$3.86
C$150.19MN/A39,418 shs1,000 shs
Klondex Mines Ltd. stock logo
KDX
Klondex Mines
C$0.00
C$1.66
C$4.85
C$553.23MN/A669,999 shs1.96 million shs
Novo Nordisk A/S stock logo
NVO
Novo Nordisk A/S
$74.03
-0.4%
$68.23
$57.00
$148.15
N/A0.667.08 million shs5.46 million shs
The 10 Best AI Stocks to Own in 2025 Cover

Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
GTT Communications, Inc. stock logo
GTT
GTT Communications
0.00%0.00%0.00%0.00%0.00%
KDI
Kennady Diamonds
0.00%0.00%0.00%0.00%0.00%
Klondex Mines Ltd. stock logo
KDX
Klondex Mines
0.00%0.00%0.00%0.00%0.00%
Novo Nordisk A/S stock logo
NVO
Novo Nordisk A/S
0.00%-8.69%+8.59%-3.71%-47.43%
CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
GTT Communications, Inc. stock logo
GTT
GTT Communications
0.5717 of 5 stars
0.00.00.03.60.03.30.0
KDI
Kennady Diamonds
N/AN/AN/AN/AN/AN/AN/AN/A
Klondex Mines Ltd. stock logo
KDX
Klondex Mines
N/AN/AN/AN/AN/AN/AN/AN/A
Novo Nordisk A/S stock logo
NVO
Novo Nordisk A/S
4.4184 of 5 stars
4.13.02.50.02.80.03.1
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
GTT Communications, Inc. stock logo
GTT
GTT Communications
0.00
N/AN/AN/A
KDI
Kennady Diamonds
0.00
N/AN/AN/A
Klondex Mines Ltd. stock logo
KDX
Klondex Mines
0.00
N/AN/AN/A
Novo Nordisk A/S stock logo
NVO
Novo Nordisk A/S
2.27
Hold$112.0051.30% Upside

Current Analyst Ratings Breakdown

Latest KDI, KDX, NVO, and GTT Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
4/28/2025
Novo Nordisk A/S stock logo
NVO
Novo Nordisk A/S
Hsbc Global Res
Subscribe to MarketBeat All Access for the recommendation accuracy rating
UpgradeStrong-Buy
4/25/2025
Novo Nordisk A/S stock logo
NVO
Novo Nordisk A/S
Dbs Bank
Subscribe to MarketBeat All Access for the recommendation accuracy rating
DowngradeSell
4/17/2025
Novo Nordisk A/S stock logo
NVO
Novo Nordisk A/S
Guggenheim
Subscribe to MarketBeat All Access for the recommendation accuracy rating
DowngradeStrong-Buy ➝ Hold
4/17/2025
Novo Nordisk A/S stock logo
NVO
Novo Nordisk A/S
BMO Capital Markets
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingOutperform ➝ Market Perform$105.00 ➝ $64.00
4/15/2025
Novo Nordisk A/S stock logo
NVO
Novo Nordisk A/S
BNP Paribas
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Initiated CoverageStrong-Buy ➝ Underperform
(Data available from 6/20/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
GTT Communications, Inc. stock logo
GTT
GTT Communications
$1.73B0.00N/A0.60$5.14 per share0.00
KDI
Kennady Diamonds
N/AN/AN/AN/AN/AN/A
Klondex Mines Ltd. stock logo
KDX
Klondex Mines
N/AN/AN/AN/AN/AN/A
Novo Nordisk A/S stock logo
NVO
Novo Nordisk A/S
$42.12BN/A$3.88 per share19.07$4.64 per shareN/A
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
GTT Communications, Inc. stock logo
GTT
GTT Communications
-$105.90MN/A0.00N/AN/AN/AN/AN/AN/A
KDI
Kennady Diamonds
N/AN/A0.00N/AN/AN/AN/AN/A
Klondex Mines Ltd. stock logo
KDX
Klondex Mines
N/AN/A0.00N/AN/AN/AN/AN/AN/A
Novo Nordisk A/S stock logo
NVO
Novo Nordisk A/S
$14.64B$3.3821.9015.891.3334.52%80.94%24.23%8/6/2025 (Estimated)

Latest KDI, KDX, NVO, and GTT Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
5/7/2025Q1 2025
Novo Nordisk A/S stock logo
NVO
Novo Nordisk A/S
$0.92$0.92N/A$0.92N/A$11.87 billion
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
GTT Communications, Inc. stock logo
GTT
GTT Communications
N/AN/AN/AN/AN/A
KDI
Kennady Diamonds
N/AN/AN/AN/AN/A
Klondex Mines Ltd. stock logo
KDX
Klondex Mines
N/AN/AN/AN/AN/A
Novo Nordisk A/S stock logo
NVO
Novo Nordisk A/S
$1.642.22%N/A48.52%N/A
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
GTT Communications, Inc. stock logo
GTT
GTT Communications
N/AN/AN/A
KDI
Kennady Diamonds
N/AN/AN/A
Klondex Mines Ltd. stock logo
KDX
Klondex Mines
N/AN/AN/A
Novo Nordisk A/S stock logo
NVO
Novo Nordisk A/S
0.70
0.74
0.56

Institutional Ownership

CompanyInstitutional Ownership
GTT Communications, Inc. stock logo
GTT
GTT Communications
81.92%
KDI
Kennady Diamonds
N/A
Klondex Mines Ltd. stock logo
KDX
Klondex Mines
N/A
Novo Nordisk A/S stock logo
NVO
Novo Nordisk A/S
11.54%

Insider Ownership

CompanyInsider Ownership
GTT Communications, Inc. stock logo
GTT
GTT Communications
46.36%
KDI
Kennady Diamonds
N/A
Klondex Mines Ltd. stock logo
KDX
Klondex Mines
N/A
Novo Nordisk A/S stock logo
NVO
Novo Nordisk A/S
0.07%
CompanyEmployeesShares OutstandingFree FloatOptionable
GTT Communications, Inc. stock logo
GTT
GTT Communications
3,10058.82 millionN/AOptionable
KDI
Kennady Diamonds
N/A50.91 millionN/ANot Optionable
Klondex Mines Ltd. stock logo
KDX
Klondex Mines
N/A180.21 millionN/ANot Optionable
Novo Nordisk A/S stock logo
NVO
Novo Nordisk A/S
77,349N/AN/AOptionable

Recent News About These Companies

Novo Nordisk: An Elite Company That Prints Money

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All Headlines
GTT Communications stock logo

GTT Communications NYSE:GTT

GTT Communications, Inc. provides cloud networking services to multinational enterprises, carriers, and government customers in the United States, Europe, and internationally. The company offers wide area networking, such as software-defined wide area networking, multiprotocol label switching, and virtual private LAN service; high bandwidth-Internet connectivity and IP transit, as well as broadband and wireless Internet access services; managed equipment and security services; and unified communication services consisting of session initiation protocol trunking, cloud unified communication service, and traditional analog voice. It also provides transport services, such as Ethernet services that enable to design network equipment; and video transport services to support broadcast quality transmission of live events, sports entertainment, and news to media and entertainment industry. In addition, the company offers infrastructure services enabling transport of high volume data between data centers, enterprise office locations, and media hubs; wavelength services to deliver scalable high-performance optical connectivity; colocation, turnkey, duct, and dark fiber services; advanced solutions, including security, hybrid cloud, database, and application management Its IP network consists of approximately 600 points of presence. GTT Communications, Inc. markets its products and services through a network of direct sales force and indirect sales channels. The company was formerly known as Global Telecom & Technology, Inc. and changed its name to GTT Communications, Inc. in January 2014. GTT Communications, Inc. was founded in 2005 and is headquartered in McLean, Virginia.

Kennady Diamonds CVE:KDI

C$2.95 -0.05 (-1.67%)
As of 04/17/2018

Kennady Diamonds Inc. engages in the discovery, evaluation, exploration, and development of diamond properties in Canada. It owns a 100% interest in the Kennady North diamond project that comprises 22 federal leases and 58 mineral claims covering an area of 67,164.17 hectares located in the north-east of Yellowknife, Northwest Territories. The company was incorporated in 2012 and is based in Toronto, Canada.

Klondex Mines stock logo

Klondex Mines TSE:KDX

Klondex Mines Ltd., together with its subsidiaries, acquires, explores, develops, and produces mineral properties in the United States and Canada. It primarily explores for gold and silver deposits. The company holds 100% interests in the Fire Creek mine covering approximately 19,000 acres located in Lander County; the Midas mine and ore milling facility covering approximately 30,000 acres situated in Elko County; and the Hollister mine approximately 18,000 acres located in Elko County. It also has 100% interests in the True North gold mine and mill covering approximately 39,868 hectares situated in Manitoba, Canada; and the Aurora mine and ore milling facility covering approximately 5,004 contiguous acres located in Nevada, as well as in the Ogama-Rockland property in Manitoba, Canada. The company was formerly known as Attila Resources Limited and changed its name to Klondex Mines Ltd. in October 1974. Klondex Mines Ltd. was founded in 1971 and is headquartered in Reno, Nevada.

Novo Nordisk A/S stock logo

Novo Nordisk A/S NYSE:NVO

$74.03 -0.32 (-0.42%)
Closing price 06/18/2025 03:59 PM Eastern
Extended Trading
$74.03 0.00 (0.00%)
As of 06/18/2025 07:58 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Novo Nordisk A/S, together with its subsidiaries, engages in the research and development, manufacture, and distribution of pharmaceutical products in Europe, the Middle East, Africa, Mainland China, Hong Kong, Taiwan, North America, and internationally. It operates in two segments, Diabetes and Obesity Care, and Rare Disease. The Diabetes and Obesity care segment provides products for diabetes, obesity, cardiovascular, and other emerging therapy areas. The Rare Disease segment offers products in the areas of rare blood disorders, rare endocrine disorders, and hormone replacement therapy. The company also provides insulin pens, growth hormone pens, and injection needles. In addition, it offers smart solutions for diabetes treatment, such as smart insulin pens and Dose Check, an insulin dose guidance application. The company has a collaboration agreement with Aspen Pharmaceuticals to produce insulin products; and with Korro Bio, Inc. for the discovery and development of new genetic medicines to treat cardiometabolic diseases. Novo Nordisk A/S was founded in 1923 and is headquartered in Bagsvaerd, Denmark.